The overall survival rate for primary peritoneal cancer may be between 11 and 17 months, according to the same 2022 review.

Ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer is a disease in which cancerous cells form in the tissues covering the ovary or lining the fallopian tube or peritoneum.

What Kind of Cancer Does Elahere Treat? Elahere treats ovarian, fallopian tube, or peritoneal cancer that is positive for the FRα protein, came back or got worse (progressed) after certain types ...

ASCO has updated its guidelines on neoadjuvant chemotherapy use in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer.

New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...

A study published in Gynecologic Oncology found decreases in the incidence and incidence-based mortality from ovarian, fallopian tube, and primary peritoneal cancer over a 15-year period.

A new FDA application for relacorilant shows promising survival benefits in treating platinum-resistant ovarian cancer, ...

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

This trial is looking at pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for cancer that has spread to the peritoneum or primary peritoneal cancer. It is open to people who have one of ...

Patients with gastric cancer peritoneal metastases (GCPM) often face an exceptionally grim prognosis, with severe symptoms and rapid disease progression.

A restaurant owner is continuing to do what he can to make his business succeed but admits "we're still not where we need to ...

The peritoneal cavity of advanced ovarian cancer patients contains the primary tumor environment and is an attractive target for a regional approach to immune modulation.